Status:
UNKNOWN
Clinical Research on the Effect of Different Extents of Internal Limiting Membrane Peeling on Macular Hole Closure and Visual Acuity
Lead Sponsor:
Wenzhou Medical University
Conditions:
Macular Holes
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Observing and describing the surgical effects of different extents of internal limiting membrane peeling combined with internal limiting membrane insertion for macular hole
Eligibility Criteria
Inclusion
- Clear diagnosis of macular hole;
- The minimum diameter of the macular hole is \>400 μm;
- Without serious systemic disease that make patients can not be operated;
Exclusion
- suffering from severe retinal diseases such as: diabetic retinopathy, age-related macular degeneration, peripheral retinal detachment, PVR, etc.;
- opacitas in the refractive medium can not perform Angio-OCT and visual acuity examination;
- eye acute and chronic inflammation, such as acute contagious conjunctivitis, acute and chronic keratitis, acute dacryocystitis;
- traumatic macular hole, secondary macular hole, high myopia macular hole, etc.;
- having a history of vitrectomy surgery;
- glaucoma in stage of preclinical, severe stenosis or closure;
Key Trial Info
Start Date :
February 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 31 2020
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT03805763
Start Date
February 1 2019
End Date
January 31 2020
Last Update
January 16 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.